Access all ESMO scientific and educational resources on this topic!
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Endocrine and Neuroendocrine Cancers
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
Cabozantinib Shows ‘Potential’ For Radioiodine-Refractory Differentiated Thyroid Cancer
Neuroendocrine Tumour Treatments Reviewed
Gastroenteropancreatic NETs Show Late Recurrence Patterns
E-Learning
ESMO E-Learning: Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumours
ESMO E-Learning: Current and Future Perspectives of Theranostics in the Field of NETs
ESMO E-Learning: Overview on Management of Lung Neuroendocrine Tumours (Typical and Atypical Carcinoids)
Meeting resources
ESMO Course
ESMO Summit Latin America 2022
Mexico City, Mexico
Side Effect Management of Ttyrosine Kinase Inhibitor Therapy and Immunotherapy
Presenter: P. Mando, AR
Session: Session 3 - Thyroid and Kidney Cancer
Resources:
Slides
Practice Changing Studies and Current Standards of Care in Thyroid Cancer
Presenter: M.E. Cabanillas, US
Session: Session 3 - Thyroid and Kidney Cancer
Resources:
Slides
PET/CT to select for and guide radioligand therapies
Presenter: Michael Hofman
Session: Molecular imaging for personalised medicine
Resources:
Slides
Webcast
121O - RATIONALE 309: A randomized, global, double-blind, Phase 3 trial of tislelizumab (TIS) vs placebo, plus gemcitabine + cisplatin (GP), as 1L treatment for recurrent/metastatic nasopharyngeal cancer (RM-NPC)
Presenter: Yunpeng Yang
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast